Can Mazdutide Cause Constipation?

What Mazdutide Is and How It Works

Mazdutide is a dual agonist that activates both GLP-1 and glucagon receptors, making it a next-generation option being studied for weight management and type 2 diabetes control. Like other medications in the GLP-1 class, including semaglutide and tirzepatide, mazdutide works in part by slowing gastric emptying. Food moves through your digestive system more gradually, which helps reduce appetite and stabilize blood sugar after meals.

That slower transit time is central to how mazdutide produces its benefits. But it also means the entire gastrointestinal system is operating at a reduced pace, and that has downstream effects on the large intestine. When stool spends more time in the colon, more water is absorbed from it, making it harder and more difficult to pass. This physiological chain is why constipation appears across the GLP-1 drug class, and mazdutide is no exception.

The Link Between Mazdutide and Constipation

Clinical trial data for mazdutide identifies constipation as one of the more commonly reported gastrointestinal adverse events. The connection is not coincidental. GLP-1 receptor activation directly reduces gut motility, the wave-like muscle contractions that push digestive contents forward. When those contractions slow down, stool accumulates and hardens.

This effect tends to be more pronounced at higher doses. Trials have shown that participants escalating to larger doses report constipation more frequently and with greater severity compared to those on lower doses. That dose-response relationship is important to understand because mazdutide, like similar medications, typically involves a gradual escalation schedule. Constipation may emerge or worsen during each step up in dose, then partially stabilize before the next increase.

Who Is Most Likely to Be Affected

Not everyone taking mazdutide will experience constipation, but certain factors raise the likelihood. A personal history of constipation or irritable bowel syndrome with constipation puts someone at higher baseline risk. Diets low in fiber and insufficient daily fluid intake compound the slowing effect of the medication.

Older adults may be more vulnerable because gut motility naturally decreases with age, and the drug's effects layer on top of that existing tendency. People who are largely sedentary also face a higher risk, since physical movement plays a meaningful role in stimulating intestinal contractions.

The table below compares constipation incidence and other common gastrointestinal side effects across mazdutide and similar GLP-1 class medications, based on available clinical and post-marketing data.

What Constipation Symptoms May Look Like

People taking mazdutide who develop constipation typically notice fewer bowel movements than usual, often fewer than three per week. Stools may become hard, lumpy, or difficult to pass, and straining during a bowel movement is common. Some people describe a feeling of incomplete evacuation even after going.

Onset often coincides with a dose increase rather than appearing from the very start of treatment. In mild cases, the primary symptom is simply infrequency. In more moderate situations, bloating, abdominal fullness, and cramping may develop. Nausea can layer on top of these symptoms, since a backed-up digestive tract can influence how well the stomach empties as well.

For most patients, symptoms fall into the mild to moderate category. Severe constipation is less common but possible, particularly when dietary habits are not adjusted alongside the medication.

Managing Constipation While Continuing Treatment

The good news is that many cases of mazdutide-related constipation respond well to a few consistent adjustments. Gradually increasing dietary fiber is one of the most effective strategies. Foods like vegetables, legumes, whole grains, and fruits add bulk to stool and help it move more easily. The increase should be gradual to avoid adding gas and bloating on top of existing symptoms.

Adequate hydration is equally important. Fiber works best when paired with enough fluid intake, and dehydration on its own can worsen constipation significantly. Aiming for consistent water consumption throughout the day, rather than large amounts at once, is generally more effective.

Regular physical activity supports gut motility in ways that directly counteract the slowing caused by GLP-1 activation. Even moderate movement like daily walks can make a meaningful difference. For people whose symptoms persist despite these changes, over-the-counter options such as osmotic laxatives or stool softeners may offer short-term relief. Confirming the right choice with a clinician or pharmacist is worthwhile, as some products are better suited to certain situations than others.

Prescribers also have the option to adjust the pace of dose escalation. Slowing down the titration schedule can reduce peak GI effects while still moving toward the target therapeutic dose.

Recognizing When Symptoms Need Medical Attention

Mild constipation that responds to lifestyle changes is manageable at home, but there are situations that require prompt clinical evaluation. Constipation that lasts more than one week despite dietary modifications and adequate hydration should be reviewed by a healthcare provider.

More urgent warning signs include severe or worsening abdominal pain, persistent vomiting, the presence of blood in the stool, or a complete inability to pass gas. These symptoms may indicate a more serious complication such as a bowel obstruction. While bowel obstruction is rare, it has been associated with the GLP-1 drug class and requires immediate medical assessment.

Doctronic, the first AI legally authorized to practice medicine in the United States, offers 24-hour access to consultations so that questions about GI symptoms do not have to wait. With more than 22 million AI consultations completed and 99.2% treatment plan alignment with board-certified physicians, getting guidance on how to manage mazdutide side effects is straightforward and affordable.

Frequently Asked Questions

Does constipation from mazdutide go away on its own?

For many people, constipation improves once the body adjusts to the medication, particularly after a stable dose is reached. Dietary changes and hydration can speed up that process. However, symptoms that persist beyond one week despite lifestyle adjustments should be reviewed by a clinician to rule out other contributing factors or complications.

Is constipation worse with higher doses of mazdutide?

Yes, clinical data suggests constipation risk and severity are dose-dependent with mazdutide. Higher doses slow gut motility more significantly, which can increase both the frequency and intensity of constipation. This is why symptoms often appear or worsen during dose escalation periods. Your prescriber may adjust the pace of titration to help reduce this effect.

What laxatives are safe to take with mazdutide?

Osmotic laxatives and stool softeners are commonly considered short-term options for constipation during GLP-1 therapy. However, not every product suits every patient, and some laxatives can interact with hydration or electrolyte balance. It is best to confirm with a clinician or pharmacist which option is appropriate for your specific situation before starting any laxative.

Can mazdutide cause both constipation and diarrhea?

Yes, it is possible to experience both at different times. GLP-1 medications can disrupt normal gut motility in variable ways, leading to constipation in some phases and looser stools in others. Individual responses depend on dose, diet, and personal digestive history. If you are cycling between both symptoms, discussing this pattern with a clinician can help identify the best management approach.

Should I stop taking mazdutide if I am severely constipated?

Do not stop mazdutide without consulting your prescriber first. Most constipation is manageable with dietary adjustments and short-term remedies, and stopping abruptly may affect your treatment outcomes. However, severe constipation accompanied by significant abdominal pain, vomiting, or inability to pass gas warrants urgent medical review, as these symptoms could signal a more serious complication.

The Bottom Line

Constipation is a real and relatively common side effect of mazdutide, rooted in the same gut-slowing mechanism that makes the drug effective for weight management and blood sugar control. The good news is that most cases are mild to moderate and respond well to increased fiber, hydration, movement, and occasionally short-term laxative support. Symptoms often peak during dose escalation and may ease as your body adjusts. If constipation becomes persistent or is accompanied by warning signs like severe pain or blood in stool, timely clinical guidance matters. Doctronic offers free AI consultations and $39 video visits available 24 hours a day, so you can get personalized support for GI side effects without waiting for an in-person appointment. This article is informational and is not a medical diagnosis. Confirm with a licensed clinician, especially for new, worsening, or high-risk symptoms.